NO310011B1 - Oftalmisk preparat og fremgangsmåte for desinfeksjon av kontaktlinser, samt fremgangsmåte for preservering av et slikt preparat - Google Patents

Oftalmisk preparat og fremgangsmåte for desinfeksjon av kontaktlinser, samt fremgangsmåte for preservering av et slikt preparat Download PDF

Info

Publication number: NO310011B1
Authority: NO; Norway
Prior art keywords: preparation; methyl; saturated; ophthalmic; unsaturated alkyl
Prior art date: 1993-09-22

Application number

NO951989A

Other languages

English (en)

Norwegian (no)

Other versions

NO951989D0 (no

NO951989L (no

Inventor

Nissanke Dassanayake

Ronald L Schlitzer

Joonsup Park

Original Assignee

Alcon Lab Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-22

Filing date

1995-05-19

Publication date

2001-05-07

1995-05-19 Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc

1995-05-19 Publication of NO951989D0 publication Critical patent/NO951989D0/no

1995-05-19 Publication of NO951989L publication Critical patent/NO951989L/no

2001-05-07 Publication of NO310011B1 publication Critical patent/NO310011B1/no

Links

230000000249 desinfective effect Effects 0.000 title claims abstract description 8
238000002360 preparation method Methods 0.000 title claims description 59
238000000034 method Methods 0.000 title claims description 27
150000001875 compounds Chemical class 0.000 claims description 48
238000004659 sterilization and disinfection Methods 0.000 claims description 14
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
229920006395 saturated elastomer Polymers 0.000 claims description 12
125000004417 unsaturated alkyl group Chemical group 0.000 claims description 12
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 8
150000003839 salts Chemical class 0.000 claims description 8
125000004171 alkoxy aryl group Chemical group 0.000 claims description 6
125000002877 alkyl aryl group Chemical group 0.000 claims description 6
125000002768 hydroxyalkyl group Chemical group 0.000 claims description 6
230000000845 anti-microbial effect Effects 0.000 claims description 5
239000004599 antimicrobial Substances 0.000 claims description 5
-1 heptadec-8-enyl Chemical group 0.000 claims description 5
239000003937 drug carrier Substances 0.000 claims description 4
238000011109 contamination Methods 0.000 claims description 3
230000000813 microbial effect Effects 0.000 claims description 3
125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 6
GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 3
SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims 3
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 3
125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
125000005065 undecenyl group Chemical group C(=CCCCCCCCCC)* 0.000 claims 3
125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
238000004140 cleaning Methods 0.000 abstract description 15
239000000203 mixture Substances 0.000 abstract description 13
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
239000000243 solution Substances 0.000 description 16
239000000645 desinfectant Substances 0.000 description 8
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
238000009472 formulation Methods 0.000 description 6
239000003755 preservative agent Substances 0.000 description 6
239000000047 product Substances 0.000 description 6
230000000694 effects Effects 0.000 description 5
238000004321 preservation Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
239000004094 surface-active agent Substances 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
239000013043 chemical agent Substances 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
208000001860 Eye Infections Diseases 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
230000000843 anti-fungal effect Effects 0.000 description 3
208000011323 eye infectious disease Diseases 0.000 description 3
229910052943 magnesium sulfate Inorganic materials 0.000 description 3
235000019341 magnesium sulphate Nutrition 0.000 description 3
239000000463 material Substances 0.000 description 3
239000012044 organic layer Substances 0.000 description 3
150000003856 quaternary ammonium compounds Chemical class 0.000 description 3
235000017557 sodium bicarbonate Nutrition 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
UNSAJINGUOTTRA-UHFFFAOYSA-N 3-(3-bromophenyl)prop-2-yn-1-ol Chemical compound OCC#CC1=CC=CC(Br)=C1 UNSAJINGUOTTRA-UHFFFAOYSA-N 0.000 description 2
101150041968 CDC13 gene Proteins 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
125000006295 amino methylene group Chemical group [H]N(*)C([H])([H])* 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
239000006172 buffering agent Substances 0.000 description 2
IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 2
NQGIJDNPUZEBRU-UHFFFAOYSA-N dodecanoyl chloride Chemical compound CCCCCCCCCCCC(Cl)=O NQGIJDNPUZEBRU-UHFFFAOYSA-N 0.000 description 2
238000000921 elemental analysis Methods 0.000 description 2
CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 2
239000000284 extract Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
238000007654 immersion Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
229910001410 inorganic ion Inorganic materials 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920001451 polypropylene glycol Polymers 0.000 description 2
239000007787 solid Substances 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
229940105325 3-dimethylaminopropylamine Drugs 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
206010015946 Eye irritation Diseases 0.000 description 1
208000010412 Glaucoma Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
CJKRXEBLWJVYJD-UHFFFAOYSA-N N,N'-diethylethylenediamine Chemical compound CCNCCNCC CJKRXEBLWJVYJD-UHFFFAOYSA-N 0.000 description 1
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000003732 agents acting on the eye Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
230000007815 allergy Effects 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
239000003945 anionic surfactant Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000000607 artificial tear Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
150000001642 boronic acid derivatives Chemical class 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
239000012459 cleaning agent Substances 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000000850 decongestant Substances 0.000 description 1
229940124581 decongestants Drugs 0.000 description 1
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
150000002171 ethylene diamines Chemical class 0.000 description 1
231100000013 eye irritation Toxicity 0.000 description 1
239000003885 eye ointment Substances 0.000 description 1
125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 1
239000000499 gel Substances 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000007794 irritation Effects 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 1
VMWJCFLUSKZZDX-UHFFFAOYSA-N n,n-dimethylmethanamine Chemical compound [CH2]N(C)C VMWJCFLUSKZZDX-UHFFFAOYSA-N 0.000 description 1
229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
BMZTZTSBZWUIKG-UHFFFAOYSA-N n-[3-(diethylamino)propyl]dodecanamide Chemical compound CCCCCCCCCCCC(=O)NCCCN(CC)CC BMZTZTSBZWUIKG-UHFFFAOYSA-N 0.000 description 1
TWMFGCHRALXDAR-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]dodecanamide Chemical compound CCCCCCCCCCCC(=O)NCCCN(C)C TWMFGCHRALXDAR-UHFFFAOYSA-N 0.000 description 1
WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
IFYDWYVPVAMGRO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NCCCN(C)C IFYDWYVPVAMGRO-UHFFFAOYSA-N 0.000 description 1
WDSHHJLKKKNVDS-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]tetradecanamide;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCCC(=O)NCCCN(C)C WDSHHJLKKKNVDS-UHFFFAOYSA-N 0.000 description 1
239000012457 nonaqueous media Substances 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
229940023490 ophthalmic product Drugs 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920001987 poloxamine Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000002791 soaking Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229940082054 sodium bicarbonate / sodium chloride Drugs 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
239000012929 tonicity agent Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
- A01N37/20—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pest Control & Pesticides (AREA)
Environmental Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Dentistry (AREA)
Engineering & Computer Science (AREA)
Plant Pathology (AREA)
Agronomy & Crop Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Apparatus For Disinfection Or Sterilisation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Detergent Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Eyeglasses (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)

NO951989A 1993-09-22 1995-05-19 Oftalmisk preparat og fremgangsmåte for desinfeksjon av kontaktlinser, samt fremgangsmåte for preservering av et slikt preparat NO310011B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/125,629 US5393491A (en)	1993-09-22	1993-09-22	Use of amidoamines in ophthalmic compositions
PCT/US1994/010695 WO1995008266A1 (en)	1993-09-22	1994-09-21	Use of amidoamines in ophthalmic compositions

Publications (3)

Publication Number	Publication Date
NO951989D0 NO951989D0 (no)	1995-05-19
NO951989L NO951989L (no)	1995-05-19
NO310011B1 true NO310011B1 (no)	2001-05-07

Family

ID=22420662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO951989A NO310011B1 (no)	1993-09-22	1995-05-19	Oftalmisk preparat og fremgangsmåte for desinfeksjon av kontaktlinser, samt fremgangsmåte for preservering av et slikt preparat

Country Status (16)

Country	Link
US (1)	US5393491A (de)
EP (1)	EP0669803B1 (de)
JP (1)	JP3073020B2 (de)
KR (1)	KR100229962B1 (de)
AT (1)	ATE187599T1 (de)
AU (1)	AU691836B2 (de)
BR (1)	BR9405606A (de)
CA (1)	CA2148615C (de)
DE (1)	DE69422153T2 (de)
DK (1)	DK0669803T3 (de)
ES (1)	ES2141843T3 (de)
FI (1)	FI109573B (de)
GR (1)	GR3032112T3 (de)
NO (1)	NO310011B1 (de)
NZ (1)	NZ274383A (de)
WO (1)	WO1995008266A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5573726A (en) *	1993-09-22	1996-11-12	Alcon Laboratories, Inc.	Use of amidoamines in ophthalmic compositions
US5631005A (en) *	1994-09-21	1997-05-20	Alcon Laboratories, Inc.	Use of amidoamines in ophthalmic compositions
WO1998025649A1 (en) *	1996-12-13	1998-06-18	Alcon Laboratories, Inc.	Use of low molecular weight amino alcohols in ophthalmic compositions
US20040033208A1 (en) *	2000-12-20	2004-02-19	Cagle Gerald D.	Antifungal compositions containing an antibiotic and one or more amidoamines
WO2002049633A2 (en) *	2000-12-20	2002-06-27	Alcon, Inc.	Use of amidoamines to treat or prevent acanthamoeba and fungal infections
US20040115160A1 (en) *	2002-12-13	2004-06-17	Salamone Joseph C.	Quaternary ammonium esters for disinfection and preservation
JP5108234B2 (ja) *	2005-02-07	2012-12-26	日本特殊陶業株式会社	マイクロヒータ及びセンサ
US20070053948A1 (en) *	2005-09-08	2007-03-08	Bausch & Lomb Incorporated	Lens care solution demonstration kit
US20070264226A1 (en) *	2006-05-10	2007-11-15	Karagoezian Hampar L	Synergistically enhanced disinfecting solutions
US8691899B2 (en) *	2007-10-09	2014-04-08	Ethicon, Inc.	Antimicrobial polymer compositions and the use thereof
US8163684B2 (en) *	2008-03-26	2012-04-24	Abbott Medical Optics Inc.	Antimicrobials having polyquaternary ammoniums and alcohol-bearing amidoamines and methods for their use
WO2011100994A1 (de) *	2010-02-19	2011-08-25	Megainpharm Gmbh	Arzneimittel enthaltend myramistin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2616713A1 (de) *	1976-04-15	1977-11-03	Hoechst Ag	Desinfektionsmittel
US4407791A (en) *	1981-09-28	1983-10-04	Alcon Laboratories, Inc.	Ophthalmic solutions
JPS6151121A (ja) *	1984-08-21	1986-03-13	Lion Corp	コンタクトレンズ用洗浄剤
US5215976A (en) *	1991-10-28	1993-06-01	Mona Industries, Inc.	Phospholipids useful as spermicidal agents

1993
- 1993-09-22 US US08/125,629 patent/US5393491A/en not_active Expired - Lifetime
1994
- 1994-09-21 AT AT94929286T patent/ATE187599T1/de active
- 1994-09-21 EP EP94929286A patent/EP0669803B1/de not_active Expired - Lifetime
- 1994-09-21 WO PCT/US1994/010695 patent/WO1995008266A1/en not_active Ceased
- 1994-09-21 DK DK94929286T patent/DK0669803T3/da active
- 1994-09-21 ES ES94929286T patent/ES2141843T3/es not_active Expired - Lifetime
- 1994-09-21 CA CA002148615A patent/CA2148615C/en not_active Expired - Lifetime
- 1994-09-21 KR KR1019950702058A patent/KR100229962B1/ko not_active Expired - Lifetime
- 1994-09-21 AU AU78398/94A patent/AU691836B2/en not_active Expired
- 1994-09-21 JP JP07509913A patent/JP3073020B2/ja not_active Expired - Lifetime
- 1994-09-21 NZ NZ274383A patent/NZ274383A/en not_active IP Right Cessation
- 1994-09-21 BR BR9405606A patent/BR9405606A/pt not_active IP Right Cessation
- 1994-09-21 DE DE69422153T patent/DE69422153T2/de not_active Expired - Lifetime
1995
- 1995-05-19 FI FI952459A patent/FI109573B/fi not_active IP Right Cessation
- 1995-05-19 NO NO951989A patent/NO310011B1/no not_active IP Right Cessation
1999
- 1999-12-16 GR GR990403036T patent/GR3032112T3/el unknown

Also Published As

Publication number	Publication date
KR100229962B1 (ko)	1999-11-15
EP0669803A1 (de)	1995-09-06
DE69422153D1 (de)	2000-01-20
JPH08503965A (ja)	1996-04-30
NO951989D0 (no)	1995-05-19
FI952459A0 (fi)	1995-05-19
CA2148615C (en)	2001-01-16
FI109573B (fi)	2002-09-13
JP3073020B2 (ja)	2000-08-07
EP0669803B1 (de)	1999-12-15
KR950703851A (ko)	1995-11-17
US5393491A (en)	1995-02-28
DE69422153T2 (de)	2000-04-06
CA2148615A1 (en)	1995-03-30
FI952459L (fi)	1995-05-19
GR3032112T3 (en)	2000-03-31
HK1011600A1 (en)	1999-07-16
AU7839894A (en)	1995-04-10
ATE187599T1 (de)	2000-01-15
NO951989L (no)	1995-05-19
NZ274383A (en)	1995-11-27
BR9405606A (pt)	1999-05-25
DK0669803T3 (da)	2000-05-15
WO1995008266A1 (en)	1995-03-30
AU691836B2 (en)	1998-05-28
ES2141843T3 (es)	2000-04-01

Legal Events

Date	Code	Title	Description
2014-09-29	MK1K	Patent expired

Publication	Publication Date	Title
US5631005A (en)	1997-05-20	Use of amidoamines in ophthalmic compositions
CA2187034C (en)	2001-02-20	Use of amidoamines in ophthalmic compositions
AU734700B2 (en)	2001-06-21	Treatment of contact lenses with aqueous solution comprising an alkali carbonate
KR100543055B1 (ko)	2006-01-20	콘택트렌즈 패킹 용액과 일회용 콘택트렌즈의 착용감을개선시키는 방법
EP1049763B1 (de)	2007-05-23	Reinigung und desinfektion von kontaktlinsen mit einem biguanid und einem borat-phosphat-puffer
DE69428202T2 (de)	2002-06-27	Enzymzusammensetzungen und verfahren zur kontaktlinsenreinigung
NO310011B1 (no)	2001-05-07	Oftalmisk preparat og fremgangsmåte for desinfeksjon av kontaktlinser, samt fremgangsmåte for preservering av et slikt preparat
WO1994015648A1 (en)	1994-07-21	Treating of contact lenses with compositions comprising pvp-h2o¿2?
US5415837A (en)	1995-05-16	Use of diamines to disinfect and clean contact lenses
US5900213A (en)	1999-05-04	Use of diamines to disinfect and clean contact lenses and preserve ophthalmic compositions
HK1011600B (en)	2000-05-12	Use of amidoamines in ophthalmic compositions
HK1011622B (en)	2000-08-04	Ophthalmic compositions comprising amidoamines
MXPA00004563A (en)	2001-07-03	Treatment of contact lenses with aqueous solution comprising an alkali carbonate
MXPA96005188A (en)	1998-07-03	Use of amidoamines in oftalmi compositions
JPS6159420A (ja)	1986-03-26	ソフトコンタクトレンズの常温消毒用及び洗浄用容液と方法
HK1031343B (en)	2003-05-16	Treatment of contact lenses with aqueous solution comprising an alkali carbonate